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Many stages of African swine fever virus infection have not yet been studied in detail. To track the behavior of African swine fever virus
(ASFV) in the infected cells in real time, we produced an infectious recombinant ASFV (B54GFP-2) that expresses and incorporates into the
virus particle a chimera of the p54 envelope protein fused to the enhanced green fluorescent protein (EGFP). The incorporation of the fusion
protein into the virus particle was confirmed immunologically and it was determined that p54-EGFP was fully functional by confirmation
that the recombinant virus made normal-sized plaques and presented similar growth curves to the wild-type virus. The tagged virus was
visualized as individual fluorescent particles during the first stages of infection and allowed to visualize the infection progression in living
cells through the viral life cycle by confocal microscopy. In this work, diverse potential applications of B54GFP-2 to study different aspects
of ASFV infection are shown. By using this recombinant virus it was possible to determine the trajectory and speed of intracellular virus
movement. Additionally, we have been able to visualize for first time the ASFV factory formation dynamics and the cytophatic effect of the
virus in live infected cells. Finally, we have analyzed virus progression along the infection cycle and infected cell death as time-lapse
animations.
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Many aspects of the infection cycle of African swine fever
virus (ASFV) remain still poorly understood. Some events of the
infection such those viral proteins involved in the virus
attachment, the intracellular transport to perinuclear areas of
the nucleus for virus replication, as well as morphogenesis and
transport events of the intracellular virus away from the factories
have been biochemically defined. However, a clear understand-
ing of these processes, how and when they occur, has beenAbbreviations: Ara-c, cytosine β-arabinofuranoside; ASFV, African swine
fever virus; β-gal, β-galactosidase; EGFP, enhanced green fluorescent protein;
ORF, open reading frame; MOI, multiplicity of infection; MW, molecular
weight; wb, western blot.
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doi:10.1016/j.virol.2006.01.021hampered by the inability to directly observe these events in
infected cells.
ASFV assembly occurs in viral factories that contain high
levels of viral structural proteins, viral DNA, and amorphous
membranous material used to produce viral envelopes. The
170-kb genome of ASFV encodes some 150 open reading
frames, and as many as 50 viral proteins are incorporated to
the viral particle (Esteves et al., 1986). Approximately 35% of
the mass of the virion is provided by p72, the major capsid
protein, while the structural proteins p150, p37, p34 and p14,
all of them derived from polyprotein p220, provides another
25% of the virion mass (Andres et al., 1997). ASFV particles
assemble within cytoplasmic viral factories from endoplasmic
reticulum-derived viral membranes (Andres et al., 1997, 1998;
Rouiller et al., 1998) at perinuclear sites (Nunes et al., 1975)
that contain fully assembled virions seen as 200-nm-diameter
hexagons in cross-section, and a series of one to six-sided
assembly intermediates (Rouiller et al., 1998). Morphological
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particles by the progressive construction of the outer capsid
layer, which is composed mainly of viral protein p72 (Garcia-
Escudero et al., 1998). Biochemical data also suggest that
protein p72 is assembled in a time-dependent fashion into
large membrane-bound complexes that may correspond to
capsid-like structures (Cobbold and Wileman, 1998). Con-
comitantly, the core shell is formed underneath the viral
envelope, and subsequently the viral DNA and nucleoproteins
are packaged and condensed to form the electrondense
nucleoid (Andres et al., 1997, 2002; Brookes et al., 1998).
Intracellular mature virions made at the assembly sites are
infectious (Andres et al., 2001). A fraction of them, however
are transported by microtubule-mediated transport (Alonso et
al., 2001; de Matos and Carvalho, 1993) to the plasma
membrane, where they are released by budding (Breese and
Pan, 1978) to give rise to the infectious extracellular
enveloped virions.
Because of the high viscosity of the cytoplasm, movement of
ASFV particles by diffusion is likely to be very limited (for
review see (Luby-Phelps, 2000). Some viruses overcome this
obstacle by hijacking cytoplasmic motors to utilize the cellular
cytoskeleton as a roadway. For instance, herpes simplex virus
HSV-1, adenovirus, ASFV and rabies virus are thought to use
dynein motors to travel along microtubule network for
intracellular transport (Alonso et al., 2001; Raux et al., 2000;
Sodeik et al., 1997; Suomalainen et al., 1999). ASFV interacts
with the dynein motor complex through the structural virus
protein p54 (Alonso et al., 2001). To further characterize the
intracellular trafficking of some of these viruses, several
fluorescence-based methods have been developed allowing
the detection and characterization of intracellular complexes of
viral origin. Importantly, several of these labeling methods
allow the visualization of individual virions in living cells
(Smith and Enquist, 2002). These studies suggest that the
intracellular trafficking of these viruses is a highly ordered
process using cellular motor pathways. Similarly, with tagged
viruses it would be possible to visualize virus morphogenesis
and cytopathic effects produced in the cells as infection
progresses.
In this report, we describe the construction of an ASF
recombinant virus, in which we have exchanged the single
copy of the p54 open reading frame in the ASFV genome,
gene E183L (Rodriguez et al., 1994) with a chimeric gene
encoding p54-EGFP. Interestingly, this virus is fully viable
and exhibits growth kinetics similar to those of its parental
virus. Moreover, p54-EGFP is incorporated into the virus
particle with the same efficiency as p54. The presence of p54-
EGFP in the virion results in fluorescent particles which are
readily visualized with a fluorescence microscope, allowing
visualization of p54-EGFP within live cells. As a consequence
of such sensitive detection of p54-EGFP throughout infection,
we have been able to use time lapse confocal microscopy to
monitor the trafficking of p54-EGFP within individual cells.
We present those results as subsequent images and time lapse
animations. Thus, we have generated a reagent which will
enable the visualization of several aspects of ASFV infectionin live cells, including virus entry, assembly, trafficking and
apoptotic cell death.
Results
Construction of a recombinant ASFV expressing p54-EGFP
fusion protein
The main goal of the molecular manipulations described
below was to generate a tagged ASF virion that allowed us
monitoring the infection in living cells. We selected the ASFV
envelope protein p54, encoded by the essential E183L gene
(Rodriguez et al., 1994), to drive the EGFP incorporation into
the virus envelope. Then, we replaced the protein p54 in the
virus particle by p54-EGFP fusion chimera in two steps. First,
we introduced in the TK gene of the virus the sequence
encoding the fusion protein p54-EGFP under the control of p54
promoter (Fig. 1a). Recombinant virus plaques exhibiting green
fluorescence were picked and individual recombinant viruses
were further plaque purified by limiting dilution and screened
by PCR and Southern blot to confirm the presence of the p54-
EGFP coding sequence in the TK locus, as expected (Fig. 1b).
The recombinant virus obtained was designated as B54GFP-1
and used to infect cells to visualize the fluorescence properties
of individual virus clones (Figs. 1c and d). Moreover, the use of
EGFP as marker gene allowed a faster detection of recombinant
viral plaques when compared to wild-type virus (data not
shown). EGFP fusion to a specific protein often modifies its
inherent properties, so we first determined whether the addition
of EGFP to the C- terminus of p54 could affect the usual
subcellular distribution of this protein. Then, Vero cells were
infected with B54GFP-1 or wild-type virus (BA71V) and
subcellular distributions of p54-EGFP and p54 were examined
by conventional immunofluorescence microscopy (Figs. 1e–j).
No differences were observed when compared, demonstrating
that typical perinuclear accumulation described for p54 in
ASFV infection was not altered by the GFP fusion.
p54 is an essential protein and then to study p54-EGFP
functionality in the virus morphogenesis and to increase the
number of copies of the tagged protein in the virions, the wild-
type E183L gene was interrupted by insertion of the β-
galactosidase coding sequence. This second step in recombinant
virus generation was performed by homologous recombination
with vector pΔp54 which contains the β-galactosidase coding
sequence under the control of p72 promoter and flanqued by
424 pb and 888 pb from p54 E183L right and left extremes,
respectively. Resulting recombinant virus plaques exhibiting
β-gal activity were picked and analyzed by PCR as well as
Southern blot to confirm the interruption of gene E183L in
the genome of ASFV (Fig. 1b). After isolation by several
rounds of plaque purification, all virus plaques exhibited both
GFP and β-galactosidase activities. The double recombinant
virus finally obtained was designated B54GFP-2 and when
used to infect cells, no trace of the wild-type p54 protein
could be detected by Western blot in cell extracts obtained at
different times of infection using a specific anti-p54 serum
(Fig. 3a).
Fig. 1. Generation of fluorescent tagged ASFV. (a) Schematic representation of the EcoRIK and EcoRIE fragments in the genome of the wild type ASFV (BA71V) and
the recombinants viruses generated (B54GFP-1 and B54GFP-2) after insertion of chimera p54-EGFP in Tk locus by homologous recombination and disruption of the
p54 gene by insertion of the β-gal marker gene, as described in Methods. E: EcoRI site. (b) Genomic analysis, after EcoRI digestion, of parental and recombinant ASF
viruses by Southern blot using a digoxigenin-11-dUTP labeled DNA probe corresponding to the p54 complete coding sequence. Size of the fragments probed was as
expected after genome manipulations. (c and d) After insertion of p54-EGFP recombinants viral plaques formed in Vero cells monolayers exhibited fluorescence and
allowed and easy detection after 5 dpi. (c) A single recombinant fluorescent plaque was photographed in a fluorescence microscope (original magnification ×100) and
correspondent transmitted light image is shown below (d). Fluorescence microscopy analysis of B54GFP-1 (e–g) or BA71V infected cells at 14 hpi (h–j). p54-EGFP
was performed by direct fluorescence (e), while p54 was detected with an anti-p54 serum and secondary antibody conjugated to Alexa 488 (h). In both cases viral and
cellular DNAwere counterstained with Hoechst to visualize viral factories, indicated by arrows (f and i). As it can be observed, in the merged images (g and j), p54-
EGFP and p54 showed similar perinuclear distribution coincident with viral factories. Scale bar, 18 μm.
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To determine that protein p54, a major component of the
external envelope of ASFV, fused to EGFP protein remains
incorporated to the viral particle, BA71Vand B54GFP-2 virions
were Percoll purified and analyzed by SDS-PAGE and Western
blotting using specific antibodies (Fig. 2a). No reactivity of anti-
GFP antibody with BA71V purified virus was found, while a
51-kDa band corresponding to the expected size of p54-EGFP
protein was detected in B54GFP-2 purified virus. However,
when an anti-p54 serum was probed, a 25-kDa band appeared
with BA71V virus and with anti-GFP serum, a 51-kDa band
was only reactive with the recombinant virus, demonstrating the
incorporation of p54-EGFP fusion protein into the virus
particles. The typical doublet detected with anti-p54 serum in
BA71V samples was not present in those from B54GFP-2 when
detection of p54-EGFP was carried out with monoclonal
antibody anti-GFP. It is noteworthy that the levels of p54-
EGFP and p54 incorporated into their respective particles were
apparently equivalent, since the amount of total virus protein
loaded in SDS-PAGE was similar in both cases, as judged byFig. 2. Incorporation of p54-EGFP into B54GFP-2 virions. (a) BA71V and reco
equilibrium gradient sedimentation (see Methods). Fractions from gradient contain
contained in samples was estimated by Coomasie blue staining and equal amounts of
by Western blot with specific antibodies: anti-GFP, anti-p54 and anti-p72. Proteins
Right: B54GP-2 particles were detected by fluorescence confocal microscopy (indic
detected with monoclonal specific antibody (Alexa fluor 647). Left: correspondent phCoomasie blue staining. In order to further confirm this, we
analyzed by Western blotting the presence of major structural
ASFV protein p72 in these highly purified virions (Fig. 2a). The
proportion of p54-EGFP relative to p72 in B54GFP-2 virions
was roughly the same as p54/p72 rate inBA71V virions,
indicating that the fusion protein was incorporated to virus
particle at similar rates than p54.
Biological properties of B54GFP-2
To ascertain the growth properties of the B54GFP-2 virus,
a time course of infection was carried out for both, wild-type
and recombinant viruses. Monolayers of Vero cells were
infected with BA71V or B54GFP-2 at a multiplicity of
infection (moi) of 5 pfu/cell and harvested at different
postinfection times. Total cell lysates were analyzed by SDS-
PAGE and Western blotting, and the kinetics of synthesis of
virus proteins were assessed (Fig. 3a). Western blotting with
an anti-p54 serum allowed the identification of a 51-kDa band,
the expected size for p54-EGFP, only in B54GFP-2 infected
cell extracts from 8 to 24 hpi. At the same times postinfection,mbinant virus B54GFP-2 were purified from culture supernatants by Percoll
ing highly purified virus free of vesicles were pooled and lysed. Total protein
protein from BA71Vand B54GFP-2 samples were electrophoresed and analyzed
were separated by SDS-12% PAGE and revealed with chemiluminescence. (b)
ated by arrowheads) at 30 min postinfection, in fixed Vero cells. β-tubulin was
ase image. N: cell nucleus. Continuous line shows cell outline. Scale bar, 18 μm.
Fig. 3. Fusion to EGFP did not alter the intrinsic properties of protein p54. (a) Vero cell monolayers were infected with BA71Vor B54GFP-2 at 5 pfu/cell. At indicated
times cells were harvested and processed for analysis of diverse virus protein synthesis by Western blot with anti-p54, anti-GFP and anti-p30 (see Methods for
dilutions). M: mock infected. (b) Cell monolayers were infected with BA71V or B54GFP-2 at 5 pfu/, in presence (+) or absence (−) of inhibitor cytosine β-
arabinofuranoside (Ara-C) to discriminate late from early viral protein synthesis. Cells were harvested at 14 hpi and analyzed by Western blot with a serum anti-p54
that recognized p54-EGFP and p54 only in absence of Ara-C. Early ASFV protein p30 was detected in presence and absence of inhibitor using monoclonal antibody
anti-p30. (c) Analysis of the replicative phenotype of B54GFP-2. Cells were infected with 0.1 pfu/cell of BA71Vor B54GFP. Every 12 hpi (for a maximum of 72)
extracellular and intracellular infectious virus progeny was estimated by plaque assays. Growth curve obtained for recombinant virus resulted similar to the parental
virus BA71V.
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while a single 51 kDa band was detected with a monoclonal
antibody against GFP, only in recombinant virus infected cell
extracts at these time points. p54-EGFP apparently remained
intact throughout the course of the infection and sample
preparation, since no doublet was observed in WB. As
expected, fusion protein was synthesized late after infection
(detectable from 8 hpi by WB), in contrast to the early protein
p30 used as a control, which was detected from 4 hpi. To
demonstrate that p54-EGFP is synthesized during the late viral
expression phase under the control of p54 promoter, we
examined the synthesis of fusion protein in the presence and
absence of a DNA replication inhibitor, such as cytosine β-
arabinofuranoside (Ara-C). In the presence of Ara-C, we could
detect neither p54-EGFP nor p54 with anti-p54 serum, while
early ASFV protein p30 expression was confirmed by WB
with a monoclonal antibody against p30 in the presence and
absence of inhibitor (Fig. 3b).These results demonstrated that virus gene expression was
similar in B54GFP-2 and wild-type virus infected cells, but it
was conceivable, since p54-EGFP is a structural component
of the virus particle, that assembly and/or release from the
cell of the double recombinant virus could be in some way
restricted. To assess the rate of virus assembly and egress
throughout several infection cell cycles, growth curves were
carried out for both B54GFP-2 and the BA71V virus. Vero
cells were infected at a multiplicity of 0.1 pfu/cell and
harvested every 10 h for 72 h, and both extracellular and
intracellular virus yields were calculated for both viruses.
The results showed that the growth curves for extracellular
and intracellular virus were similar for wild-type and
recombinant virus infections, not only in total infectious
virus production after 72 hpi, but at every time point we
examined (Fig. 3c). These results imply that the rates of both
virus assembly and virus egress from the cell were the same
for the two viruses.
Fig. 4. p54-EGFP intracellular distribution at the viral factory in B54GFP-2
infection. Vero cells infected with B54GFP-2 were analyzed by confocal
immunofluorescence microscopy at 12 hpi (a–d). (a) β-tubulin was labeled with
monoclonal anti-β-tubulin antibody conjugated to Alexa 647, while p54-EGFP
was detected by direct fluorescence (b). Staining of viral and cellular DNAwith
Hoechst 33342 (c) allowed the identification of perinuclear viral factories
(indicated by arrows) where replication of ASFV DNA occurs. (d) Colocaliza-
tion of p54-EGFP with viral factories is shown in the merged imaged. (e–g)
Golgi complex was detected in B54GFP-2 infected live cell, by staining with
Bodipy-TRC5-ceramide (f). Merged imaged (g) shows the perinuclear
distribution of Golgi complex surrounding p54EGFP (e), but not coincident.
Scale bar, 20 μm.
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The incorporation of p54-EGFP into virions of the ASFV
B54GFP-2 makes possible that these particles can be detectable
by fluorescence. To test if this was the case, virions purified by
sedimentation through sucrose cushion were used to infect Vero
cells grown onto a coverslip at a multiplicity of 10 pfu/cell.
After synchronizing the infection at 4 °C for 2 h, cells were
incubated for 30 min at 37 °C and subsequently examined by
fluorescence microscopy. Fluorescent particles, visualized as
point sources of GFP fluorescence, were readily detected inside
cell cytoplasm (Fig. 2b). When target cells were washed of free
virus and allowed to incubate further at 37 °C, a significant
proportion of the GFP signal accumulated in the perinuclear
region, in a short time after infection 4 h (Additional file 1).
Images were acquired at 30 min and 4 h postinfection, before
late viral protein expression phase onset to avoid that observed
GFP signal corresponds to newly synthesized p54-EGFP.
p54-EGFP distribution in the viral factory in late infected cells
Some obvious applications of a virus expressing a
fluorescent structural protein would be to localize that protein
within the cell and follow its trafficking during the infection
cycle and ultimately, to visualize the pathway of virus assembly
in live cells. As previously shown, wild-type p54 and p54-
EGFP distribution at late times in wild type and B54GFP-1
infection was shown in perinuclear viral factories (Figs. 1e–j).
We examined this distribution for B54GFP-2 infected cells at
12–16 hpi by confocal fluorescence microscopy in fixed cells
(Figs. 4a–d). Protein p54-EGFP distribution coincided with
assembly sites in the viral factories, which is characterized by a
great accumulation of newly synthesized viral DNA. To further
confirm that p54-EGFP distribution could be used as a novel
viral factory marker in ASFV infection we showed that the
Golgi complex in living B54GFP-2 infected cells was located
surrounding, but not coincident with the viral factory where a
great accumulation of p54-EGFP is found (Figs. 4e–g).
Time lapse analysis of virus infection
The ultimate elegance of a GFP-incorporating virus is the
potential for monitoring virus infection in individual living
cells. The abundant incorporation of p54-EGFP into ASFV
particles indicated that it should be possible to visualize the
intracellular movement of virions in real time by laser-scanning
confocal microscopy of live cells. Approximately 50%
confluent Vero cells were infected with more than 10 PFU of
B54GFP-2 virus per cell. Virus infection was synchronized by
incubation of cells at 4 °C for 90 min and images were collected,
after incubation at 37 °C for nearly 2 h, to analyze the first steps
of infection at high magnification. Individual virus particles
were readily observed and images were acquired with the
confocal microscope setup at a rate of 1 frame/3s for a
maximum of 2 min. With this short interval of time, we
discerned that intracellular movement in the proximity of
perinuclear areas was composed of frequent stops and starts,and often without any apparent direction. Fig. 5 shows an
example of this intermittent or saltatory movement of an
individual virion. Over the times and distances measured in
following frames acquired from 10 different virions, an average
speed ranged from 0.2 to 0.5 μm/s at this stage of infection was
calculated. In order to test the role of microtubules at this stage
of infection, disruption of microtubules with 10 μM nocodazole
was achieved prior to infection with B54GFP-2. Under these
conditions we could not track any virion movement examined at
1 hpi or 4 hpi in live cells. Interestingly, at mentioned times
postinfection most GFP signal was localized far from peri-
nuclear areas in contrast to infected cells with intact
microtubules (Additional file 2).
To determine the stage of infection at which newly
synthesized p54-EGFP could initially be detected by direct
fluorescence microscopy, and to visualize virus factory
constitution, Vero cells were infected with B54GFP-2 at a
multiplicity of infection of 1 pfu/cell. After synchronization of
the infection, cells were examined for EGFP fluorescence every
Fig. 5. Analysis of the intracellular movement of B54GFP-2 viral particles. Vero cells were B54GFP-2 infected with 20 pfu/cell and examined by confocal microscopy
at 1 hpi, acquiring images every 3 s corresponding to 0.5 μm optical sections from the Z axis. Virus particles were detected as EGFP point sources, and correspondent
transmitted light image provided points of reference information. Movement of 10 virions were individually analyzed. Upper image shows an example of the trajectory
followed by one of the virions analyzed (white discontinuous line) and selected area is enlarged below. Total distance covered by this virion was 11.74 μm in 30 s, with
an average speed of 0.5 μm/s. As can be observed in the figure, virion velocity was not constant, with a maximum speed from 12 to 15 s. Scale bar, 8μm as indicated.
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Representative images collected at indicated time points are
shown in Fig. 6. Protein p54-EGFP was first observed in the
majority of cells as early as 7–8 hpi. The protein was mainly
localized as small, cytoplasmic and fluorescent aggregates
around the nucleus (2 or 3 spots were usually observed within
single cell). From this point, all of these perinuclear spots finally
aggregated along the next 2 h to give rise to a unique brilliant
spot close to the nucleus (Fig. 6b). This accumulation of p54-
EGFP, which was previously shown coincident to the viral
factory, gradually increased in size and fluorescence intensity as
infection proceeded. It should be mentioned that aggregation of
initial perinuclear spots of p54-EGFP could not be observed in
every infected cell, but in most of them, probably due to
changes in the optical section acquired during the monitoring of
the infection. At late times postinfection, in most of the cells, it
was usually to observe violent changes in viral factories location
(Fig. 6a), however these changes seem to correspond to
movements of infected cell prior to detachment from the dish,
while factory location is conserved.
In another set of experiments, we investigated the
relationship, of mitochondria status and viral factory forma-
tion in a time course manner. At initial infection steps
mitochondria were observed as an almost continuous
succession of organelles extending throughout the cytoplasm.
Nevertheless, time lapse experiments with image acquisitions
every 5 min in Vero cells infected at a moi of 1 pfu/cell,
showed the progressive alteration of the normal mitochondrial
pattern and mitochondrial irregular clumping and aggregation
around viral factory was observed (Fig. 8). This aggregation
started at 8 h after infection, coincident with p54-EGFPsynthesis, suggesting the high energy requirements of the
virus assembly process.
Apoptosis has been described to play an important role in
ASFV pathogenesis (Ramiro-Ibanez et al., 1996), so we
decided to analyze the very late stages of ASFV infection in
living cells infected with B54GFP-2. Fig. 7 shows in detail
the characteristic morphological changes that occur during
programmed cell death of an infected cell. Since 12 hpi an
early cytopathic effect, consisting in cytoplasmic vacuoliza-
tion, rounding and reduction in the size of the infected cell
was be observed. From this time point onwards, the cell lost
contacts with neighboring cells and detached from the
monolayer, undergoing nuclear fragmentation and final cell
death. This process included typical membrane blebbing of
the infected cell that led to the formation of numerous
vesicles containing large amounts of p54-EGFP. Vesicle
formation has been considered a very characteristic feature
of ASFV infection in cultured cells and these are virus-
containing vesicles. Completion of the process from the first
morphological features of apoptosis lasted around 6 h.
Discussion
Successful African swine fever virus life cycle is dependent
on several and critical interactions with host cell which remain
poorly understood. Some of these events include virus
internalization into cellular cytoplasm, transport to perinuclear
areas where viral DNA replication occurs, egress of viral
progeny from assembly sites to cell periphery and virus induced
cell death. Recent improvements in optical imaging techniques
combined with protein fusion to GFP variants, open new
Fig. 6. Constitution of the viral factory in B54GFP-2 infected live cells. Vero cells were B54GFP-2 infected with 1 pfu/cell. After infection synchronization, cells were
maintained at 37 °C for the complete image acquisition period. (a) p54-EGFP (green) and transmitted light images of the same B54GFP-2 infected cell were
simultaneously acquired by confocal microscopy at indicated times postinfection. The progressive accumulation of p54-EGFP in perinuclear areas from 7 hpi and the
violent movements of the infected cell prior to detachment from dish are observed. Scale bar, 18 μm. (b) Images, collected in the same way, from 6 hpi show the
aggregation of several perinuclear and bright p54-EGFP spots (indicated by arrowheads in 8 hpi image) that resemble aggresomes, to constitute a unique and final viral
factory in the infected cell. Scale bar, 20 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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This new methodology has been successfully applied to study
different aspects of the infection of adenoviruses (Lux et al.,
2005), herpesviruses (Glotzer et al., 2001; Sampaio et al., 2005),
poxviruses (Geada et al., 2001; Hollinshead et al., 2001; Ward
and Moss, 2001), rhabdoviruses (Finke et al., 2004) or
retroviruses (McDonald et al., 2002; Muller et al., 2004). We
reported here the generation of a fluorescently tagged and viable
ASFV expressing the structural protein p54 as an EGFP fusion
protein. Expression of p54-EGFP enables easy identification of
infected cells by direct fluorescence analysis, which results
useful when immunodetection of diverse antigens in the same
sample is desirable.
Selection of p54 as the viral fusion protein was supported by
several reasons. Since p54 is located in the inner viral envelope
(Rodriguez et al., 1994), fluorescent p54 would allow the
detection of individual viral particles upon infection. As the
carboxi- terminal tail of p54 is facing the surface of mature
virions, it was expected to be a suitable target for EGFP fusion.
On the other hand, newly synthesized p54 accumulates within
perinuclear areas where morphogenesis takes place at late timespostinfection. Thus, p54-EGFP could become a very helpful
tool to analyze viral factories assembly.
The strategy to generate tagged virus B54GFP-2, consisted in
two sequential steps. After initial insertion of p54-EGFP coding
sequence under the control of p54 promoter, it was found that
fusion of EGFP to the C-terminus of p54 did not affect the
perinuclear subcellular distribution of the viral protein, as it was
directly observed in B54GFP-1 infected cells. Then, we
interrupted E183L gene in B54GFP-1 genome by insertion of
β-galactosidase coding sequence as second selection marker, to
ensure that every p54 molecule that accommodates in virion
inner envelope would be EGFP tagged. Previously, p54 has been
shown to be essential for virus viability, playing and important
role in ASFV morphogenesis (Rodriguez et al., 1996, 2004), so
the recovery of recombinant virus B54GFP-2 after wild type p54
interruption indicated that fusion did not apparently affect the
normal function of p54. Furthermore, growth curves obtained
with recombinant virus indicated identical replication behavior
and infectious efficiency when compared to the parental strain.
Furthermore, fusion to EGFP did not alter the expression
pattern determined by WB analysis for p54 in infection as p54-
Fig. 7. Live-cell analysis of the last stages of B54GFP-2 infection. Series of EGFP and transmitted light simultaneous acquisitions of the same B54GFP-2 infected Vero
cell by confocal microscopy from 10 hpi (when viral factory is already constituted) and every 5 min (see additional file 3 to complete animation sequence). Rounding
of the infected cell is followed by membrane blebbing and subsequent formation of p54-EGFP (green) containing vesicles. At 18 hpi, detachment and final cell
destruction is observed. Scale bar, 20 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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promoter in B54GFP-2. P54-EGFP was synthesized and
detected during late viral expression phase, from 8 hpi, as
expected. This observation was confirmed by WB analysis in
the presence of inhibitor Ara-C, which demonstrated that there
was not chimera protein expression when viral DNA replication
was inhibited. Also, expression levels of p54-EGFP in
infection, determined by WB, did not apparently differ from
those observed for p54.
In order to track single fluorescent ASFV particles, it is an
essential requirement that p54-EGFP is incorporated into viral
particles. Previously, p54 has been successfully used as a target
to generate ASFV chimeras incorporating short foreign viral
epitopes such as the antigenic site A from foot-and-mouth
disease virus VP1 protein and the DA3 antigenic determinant
from transmissible gastroenteritis coronavirus nucleoprotein N
(Brun et al., 1999). In both cases, chimeric p54 proteins weresuccessfully incorporated into the viral particles, supporting
selection of p54 as the fusion protein. As expected, Western blot
with Percoll purified B54GFP-2 particles demonstrated the
association of p54-EGFP with ASFV virions. As deduced from
detection of control protein p72 and p54 in Percoll purified
samples, inclusion of p54-EGFP into virions appeared to occur
with same effectiveness than p54.
Such tagged virus will enable live analysis of various stages
in the ASFVreplicative cycle using confocal microscopy. One of
these potential applications of B54GFP-2, shown in present
work, would be the analysis of intracellular movements of
fluorescent particles during the initial phase of infection
immediately after internalization into the host cell. When
collecting confocal microscopic images every 3 s, from 2 hpi,
it was found that most of the viral particles exhibited a special
kind of movement defined as saltatory, intermittent and
apparently disorganized, making difficult the estimation of
Fig. 8. Live-cell analysis of mitochondria in B54GFP-2 infection. Vero cells were
infected with 1 pfu/cell and synchronization of infection was achieved. Live
mitochondria (red) were detected with CMXRos. (a) At early stages of infection,
mitochondria are disposed as a continuous ring throughout the cytoplasm. (b)
Initial aggregation of mitochondria around newly synthesized p54-EGFP (green)
was observed since 8 hpi. (c) Aggregation of mitochondria around virus factories
can be observed in late infected cells (indicated by arrows), while disposition of
mitochondria in non infected cells is typical of healthy cells. Selected area is
enlarged in image d. Images were acquired by confocal fluorescence microscopy
every 5 min from 6 hpi. Scale bar, 20 μm. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this
article.)
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characteristic of microtubule associated movement. From the
analysis of movement of 10 individual virions an average speed
ranging from 0.2 to 0.5 μm/s was calculated with the applied
resolution. These data are in agreement with those obtained for
other large enveloped viruses. Using fluorescence videomicro-
scopy, which allows a resolution of 1 frame/s, speed rates from
0.3 to 1 μm/s have been determined during the late phase of
infection with labeled vaccinia virus (Geada et al., 2001; Ward,
2005;Ward andMoss, 2001). Recently, human cytomegalovirus
has been shown to move with apparent velocity of 0.7 to 0.8 μm/
s (Sampaio et al., 2005) at very early stages in infection.
Moreover, HIV virions transport towards host cell nucleus
linked to microtubules occurs at 1 μm/s (McDonald et al., 2002).
The saltatory movements of tagged ASFV virions and the speed
rates obtained are consistent with a microtubular based transport
(King, 2000) and association of this virus with microtubules has
been described (de Matos and Carvalho, 1993). Previously, we
identified the LC8 subunit of cytoplasmic dynein, a minus end
directed microtubule-associated motor protein, as an interacting
protein with p54 (Alonso et al., 2001), resulting this interaction
critical in the first stages of ASFV infection. Collectively, these
data suggested a role for microtubules in the intracellular
transport of ASFVafter internalization. This role is supported by
data showing that nocodazole disruption of microtubules prior toinfection results in stop of virion movement and lack of
perinuclear accumulation of viral particles at 4 hpi that remained
dispersed in the cytoplasm. Also, there was no subsequent
constitution of the characteristic virus factory and finally a
reduction in ASFV progeny was found (additional files 1 and 2
and Alonso et al., 2001). Also, during the late phase of ASFV
infection, transport of newly assembled virions from viral
factory to cell periphery along microtubules has been recently
demonstrated (Stefanovic et al., 2005), similar to the exit
transport described for vaccinia virus (Carter et al., 2003).
Further live studies involving labeled B54GFP-2 that are now in
course will provide useful and detailed information to clarify the
whole ASFV penetration and egress process into the host cell.
P54 has been previously described to localize in membrane
structures within the virus factories and in immature ASF
virions, as judged by immunogold electron microscopy
(Rodriguez et al., 1994). P54-EGFP, just as p54, showed an
intracellular distribution fully coincident with ASFV factory at
late postinfection times. This allowed us, to follow the viral
factory formation process in live cells throughout the infection
cycle for first time. Animations obtained show that p54-EGFP
was first detected in cytoplasm as several discrete and bright
spots representing initial viral assembly sites. As infection
progresses these initial assembly sites migrated to a perinuclear
area, fused and finally formed a single large accumulation of
p54-EGFP per cell. Similar assembly sites were previously
described as viral antigens inclusions containing viral pre-
cursors which remained tightly associated to microtubules
(Carvalho et al., 1988). Indeed, microtubule associated motors
are required to transport these initial assembly sites towards the
microtubule organization center (MTOC), where final ASFV
factory is constituted (Alonso et al., 2001; Heath et al., 2001)
following viral replication and viral assembly takes place. First
steps in ASFV assembly consist in the modification of ER
membranes (Andres et al., 1998; Rouiller et al., 1998). Protein
p54 has been involved in the recruitment to the viral factories
and transformation of the ER-derived envelope precursors that
are finally acquired by virions (Rodriguez et al., 2004). This
new role for p54 in morphogenesis supports the selection of p54
as viral fusion protein and suggests that studies about p54-
EGFP trafficking during infection in live cells would be helpful
to analyze the acquisition of ASFV envelopes from ER during
virus assembly.
The formation of the viral factory often involves not only
host cytoplasmic membranes and cytoskeletal components, but
also cell organelles such as mitochondria. These are thought to
play an important role in several large DNA enveloped virus
infections (Murata et al., 2000; Novoa et al., 2005; Rojo et al.,
1998), supplying the energy required in the morphogenetic and
assembly processes. Our results, obtained with live ASFV
infected cells have confirmed these previous observations in
fixed cells (Hernaez et al., 2004a; Rojo et al., 1998), which
showed that ASFV infection induce the migration of
mitochondria to the perinuclear assembly sites, producing the
clustering of this actively respiring organelle around viral
factory. This migration occurs since 8 hpi, before the definitive
viral factory is fully constituted, suggesting that energy
11B. Hernaez et al. / Virology 350 (2006) 1–14contribution from mitochondria is required since first stages of
ASFV morphogenesis.
Finally, we analyzed the destruction of the ASFV infected
cell. This process started at 12 hpi and usually lasted about 6 h,
being identical to apoptotic cell death, which has been
demonstrated to play a relevant role in ASFV pathogenesis
(Hernaez et al., 2004a, 2004b; Ramiro-Ibanez et al., 1996). In
live cells, it was possible to observe host cell membrane
blebbing, resulting in the formation of p54-EGFP containing
vesicles. This finding raised the possibility that these vesicles
could contain virus particles. Previous publications reported
that the abundant vesicle fraction released in last ASFV
infection stages contains virus (Carrascosa et al., 1985). Then,
it is conceivable that the fluorescence detected in the vesicles
formed at the end of apoptosis (blebbing), could correspond to
GFP labeled virus particles. This vesicle formation observed in
live cells is rarely observed using common fixation methods,
then it is not possible to observe it with the parental unlabeled
virus.
In summary, we have generated a fluorescently tagged
ASFV, which could be a powerful tool since it enables live
analyses of diverse aspects of ASFV live cycle, including viral
particles intracellular transport, morphogenesis and apoptosis of
the infected cell. We presented here, for the first time, live
images of some of these stages in ASFV infection and more
detailed information will arise from future and novel studies of
virus entry and egress.
Methods
Cells, viruses and plasmids
Vero cells were obtained from ECACC and grown at 37 °C
in a 5% CO2 atmosphere in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 5% foetal bovine serum
(FBS). ASFV isolate BA71V, adapted to grow in Vero cells, was
used in infection experiments carried out at 37 °C and 5% CO2.
When synchronization of infection was required, this was
performed for 90 min at 4 °C after viral inoculum was added. In
most cases, ASFV stocks from culture supernatants were
semipurified from vesicles by ultracentrifugation at 40.000 × g
through a 20% (w/v) sucrose cushion in PBS for 1 h at 4 °C.
When needed, ASFV particles were highly purified from the
extracellular medium by Percoll equilibrium centrifugation as
previously described (Carrascosa et al., 1985). After centrifu-
gation, Percoll gradients were fractionated and fractions 2 to
8 from Percoll gradients, containing virus particle essentially
free of vesicles and contaminant membranes, were collected
after sedimentation and gel filtered through Sephacryl S-1000
(Amersham) to remove Percoll.
The construction of the insertion vector pINS-54EGFP
involved several steps. The expression plasmid pEGFP-N1
(Clontech) was used as template to obtain the EGFP coding
sequence by PCR with specific primers (5′-CGCGGATCCGC-
AGTAAAAAAATG-3′ and 5′-CGCGGAATTCATGGTGAG-
CAAGGGC-3′). A fragment of 800 pb corresponding to p54
promoter and complete p54 coding sequence was also obtainedfrom BA71V genome by PCR with specific primers (5′-
GCGGGATCCCGTTGTCTAGGTAA-3′and 5′-GCGGAATT-
CCAAGGAGTTTTCTAGG-3′). In order to generate the vector
pINS-54GFP, previous PCR products were digested with EcoRI
and BamHI and cloned into the 4.7 kpb fragment resulting from
the digestion of plasmid pINS72Gal (Gomez-Puertas et al.,
1995; Rodriguez et al., 1992) with BamHI.
The construction of the vector pΔp54, used to perform the
interruption of E183L gene, was described previously (Rodri-
guez et al., 1996). Briefly, this vector contains β-galactosidase
coding sequence under control of p72 promoter, flanked by two
fragments from E183L that allow homologous recombination
with this ORF in BA71V genome. These flanking sequences
correspond to 424 pb and 888 pb from right and left extremes
from p54 gene, respectively.
Construction of B54GFP-2
An African swine fever virus recombinant expressing an
enhanced version of the GFP gene (EGFP) fused to the C-
terminus of the p54 coding sequence was constructed in two
steps: first, the insertion of the p54-EGFP coding sequence into
thymidine kinase locus (TK) in BA71V genome was achieved
by homologous recombination after transfection of Vero cells
with pINS-p54EGFP in the presence of Fugene (Roche),
according to manufacturer's instructions. Eight to 16 h after
transfection, cells were infected with BA71Vat a moi of 0.1 pfu/
cell. When the cytophatic effect was complete (approximately
72 hpi) the cultures were harvested and sonicated. These
transfection-infection mixtures were used to infected mono-
layers of Vero cells seeded onto 100 mm dishes (Nunc) at
different dilutions. After 5–6 dpi, the recombinant virus
generated was isolated from progeny virus by three rounds of
plaque purification on Vero cells, during which recombinant
virus plaques were screened for EGFP direct fluorescence. The
resulting recombinant virus was named B54GFP-1. Additional
second step consisted in the inactivation of the original gene of
p54 (E183L) in the B54GFP-1 genome to finally generate the
recombinant virus B54GFP-2. The transfection of Vero cells
with pΔp54 and following infection with B54GFP-1 allowed
the insertion of the β-galactosidase coding sequence down-
stream of the strong p73 promoter within E183L gene. Isolation
of B54GFP-2 was performed as described above, screening
recombinant virus plaques for EGFP fluorescence and expres-
sion of β-galactosidase (Gomez-Puertas et al., 1995).
The genomic structure of these recombinant viruses was
confirmed by DNA hybridization analysis and could be
observed in Figs. 1a and b. Briefly, DNA from parental and
recombinant viruses were obtained and purified as previously
described (Esposito et al., 1981). Resulting fragments, after Eco
RI digestion, were resolved by agarose gel electrophoresis and
then blotted onto uncharged Nylon membranes (Amersham).
Membranes were probed with a digoxigenin-11-dUTP labeled
DNA fragment corresponding to the complete p54 coding
sequence. Final detection of digoxigenin was performed with
CSPD (Roche) after probing the membrane with specific
monoclonal antibody anti-digoxigenin (Roche).
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Preconfluent monolayers of Vero cells were infected with
either recombinant B54GFP-2 or parental BA71V at 0.1 pfu/
cell. After 90 min, inoculum was removed and cells were
washed with fresh DMEM and overlaid with DMEM
supplemented with 2% FBS. Infected cells with their culture
supernatants were harvested at different times postinfection (0,
12, 24, 48 and 72 hpi) and centrifuged at 3000 × g for 10 min.
Cell pellets was resuspended in DMEM. Both the cellular
fraction and the supernatant were sonicated and separately
titrated by plaque assay to determine the intracellular and
extracellular virus production respectively.
Plaques assays were performed as described previously
(Gomez-Puertas et al., 1995). When isolation of recombinant
virus plaques was desired, detection of EGFP fluorescence and
expression of β-galactosidase were performed at 4 and 6 days
postinfection respectively.
Immunoblot analysis
Vero cells preconfluent monolayers seeded on 6-well plates
were infected with BA71Vor B54GFP-2 at a moi of 5 pfu/cell.
When inhibition of late viral protein synthesis was required,
cells were incubated with cytosine β-arabinofuranoside (Ara-C)
50 μg/ml at 3 hpi. In all cases, cells were washed with PBS and
harvested at 0, 4, 8, 12 and 24 hpi and lysed in RIPA buffer.
After centrifugation at 10,000 × g for 20 min, proteins from
cleared lysates were electrophoresed in 12% SDS-polyacryl-
amide gels and transferred to nitrocelluose membranes
(BioRad). Membranes were incubated for 2 h at room
temperature in PBS containing 5% non-fat dry milk and then
probed with corresponding primary antibodies: monoclonal
antibody anti p30 diluted 1:500, monoclonal antibody anti-GFP
diluted 1:2500 (Clontech), and specific serum against p54
raised in rabbit diluted 1:1000, for 1 h at room temperature in
PBS containing 0.05% Tween 20 (PBS-T). After extensive
washing with PBS-T, membranes were incubated with anti
mouse IgG antibody (diluted 1:5000) conjugated to horseradish
peroxidase (Amersham) or anti rabbit IgG (diluted 1:4000)
conjugated to horseradish peroxidase (Amersham).
In other experiments, proteins from ASFV highly purified
particles were analyzed by Western blotting in the same way,
but membranes were probed with monoclonal anti-GFP
antibody, monoclonal anti-p72 antibody and polyclonal specific
antibody anti-p54 raised in rabbit (diluted 1:1000). Anti mouse
IgG antibody (diluted 1:5000) and anti rabbit IgG antibody
(diluted 1:4000) conjugated to horseradish peroxidase (Amer-
sham) were used as secondary antibodies respectively. In all
cases, final detection on membranes was performed with ECL
Western detection reagent (Amersham) and exposure to X-ray
films (Kodak).
Fluorescence microscopy of fixed cells
Vero cells were grown on coverslips at 50–60%
confluency and then infected with BA71V or recombinantviruses at different moi depending on the experiment. At
desired time postinfection cells were rinsed twice with PBS
and fixed with PBS containing 4% paraformaldehyde for 10
min at room temperature. When permeabilization was
required, cells were incubated in presence of 0.1% Triton
X-100 for 15 min at room temperature. A monospecific
antiserum against p54 was raised in rabbit and used to
visualize p54 (diluted 1:300). To detect tubulin a monoclonal
antibody against β-tubulin (Sigma) was used (diluted 1:200).
Secondary antibodies used were an anti rabbit IgG antibody
conjugated to Alexa 488 fluor (Molecular Probes) and anti
mouse IgG antibody conjugated to Alexa fluor 647
(Molecular Probes). Specificity of labeling and absence of
signal crossover were determined by examination of single
labeled control samples. p54-EGFP was directly observed by
detection of fluorescence at λ = 509 nm. Nuclei as well as
DNA in virus factories were detected by staining with
Hoechst 33342. Finally, cells were mounted onto slides using
Fluorsave reagent (Calbiochem).
Conventional microscopy was carried out in a Leica
photomicroscope with a digital camera, and digitized
images were obtained with Qwin software (Leica).
Confocal microscopy was carried out in a Leica confocal
microscope TCS SP2-AOBS equipped with a 63 or 100×
objectives.
Fluorescence microscopy of live cells
Vero cells were plated at 60% confluence onto 35 mm
dishes (WillCo Wells) and infected with 1 or 20 pfu of
B54GFP-2 per cell, depending on the experiment. For the
majority of experiments, synchronization of virus infection
was achieved by performing the adsorption at 4 °C for 90
min and following removal of unbound virus. At indicated
time points, cells were imaged by confocal microscopy
carried out in a Leica confocal microscope TCS SP2-AOBS.
In either case, cells were maintained on a heated 35 mm
stage with the temperature set at 37 °C and fresh DMEM
supplemented with 2.5% fetal bovine serum was perfused
onto the dish at a rate of 0.1 ml/min throughout the
experiment. The acquisition of images was every 5 min in
long experiments (4 to 8 h length) and every 2–3 s in
shorter experiments (from 1 to 4 hpi). Nevertheless, in long
experiments only indicated postinfection times images are
shown in figures. Simultaneous acquisition of EGFP
fluorescence emission and transmitted light was performed.
Microtubules depolymerization was achieved with 10 μM
nocodazole (Sigma) 2 h before the infection without
removing it during the acquisition of images. Detection of
mitochondria in live cells was carried out with MitoTracker
Red CMXRos (Molecular Probes) 100 nM for 30 min after
virus infection. Golgi complex was detected in live cells
with 5 μM Bodipy-TRC5-ceramide complexed to BSA
(Molecular Probes) for 30 min before infection, and emission
detected at λ = 617. Manipulation and subsequent analysis
of acquired images were carried out with Leica Confocal
Software v.2.0.
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